Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA; Surgery Service, Veterans Affairs Medical Center, Baltimore, MD, USA.
Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA; Surgery Service, Veterans Affairs Medical Center, Baltimore, MD, USA.
Am J Surg. 2021 Aug;222(2):431-437. doi: 10.1016/j.amjsurg.2020.12.024. Epub 2020 Dec 28.
Reports on emergency surgery performed soon after a COVID-19 infection that are not controlled for premorbid risk-factors show increased 30-day mortality and pulmonary complications. This contributed to a virtual cessation of elective surgery during the pandemic surge. To inform evidence-based guidance on the decisions for surgery during the recovery phase of the pandemic, we compare 30-day outcomes in patients testing positive for COVID-19 before their operation, to contemporary propensity-matched COVID-19 negative patients undergoing the same procedures.
This prospective multicentre study included all patients undergoing surgery at 170 Veterans Health Administration (VA) hospitals across the United States. COVID-19 positive patients were propensity matched to COVID-19 negative patients on demographic and procedural factors. We compared 30-day outcomes between COVID-19 positive and negative patients, and the effect of time from testing positive to the date of procedure (≤10 days, 11-30 days and >30 days) on outcomes.
Between March 1 and August 15, 2020, 449 COVID-19 positive and 51,238 negative patients met inclusion criteria. Propensity matching yielded 432 COVID-19 positive and 1256 negative patients among whom half underwent elective surgery. Infected patients had longer hospital stays (median seven days), higher rates of pneumonia (20.6%), ventilator requirement (7.6%), acute respiratory distress syndrome (ARDS, 17.1%), septic shock (13.7%), and ischemic stroke (5.8%), while mortality, reoperations and readmissions were not significantly different. Higher odds for ventilation and stroke persisted even when surgery was delayed 11-30 days, and for pneumonia, ARDS, and septic shock >30 days after a positive test.
30-day pulmonary, septic, and ischaemic complications are increased in COVID-19 positive, compared to propensity score matched negative patients. Odds for several complications persist despite a delay beyond ten days after testing positive. Individualized risk-stratification by pulmonary and atherosclerotic comorbidities should be considered when making decisions for delaying surgery in infected patients.
有报道称,在 COVID-19 感染后不久进行的紧急手术,如果不考虑发病前的风险因素,30 天死亡率和肺部并发症会增加。这导致在大流行高峰期几乎停止了择期手术。为了为大流行恢复期的手术决策提供循证指导,我们将手术前检测出 COVID-19 阳性的患者与接受相同手术的同时期 COVID-19 阴性患者的 30 天结局进行比较。
这项前瞻性多中心研究纳入了美国退伍军人事务部(VA)170 家医院的所有手术患者。对 COVID-19 阳性患者进行倾向评分匹配,以匹配 COVID-19 阴性患者的人口统计学和手术因素。我们比较了 COVID-19 阳性和阴性患者的 30 天结局,并比较了从检测阳性到手术日期的时间(≤10 天、11-30 天和>30 天)对结局的影响。
2020 年 3 月 1 日至 8 月 15 日,共有 449 例 COVID-19 阳性和 51238 例阴性患者符合纳入标准。倾向评分匹配得到 432 例 COVID-19 阳性和 1256 例阴性患者,其中一半接受了择期手术。感染患者的住院时间更长(中位数为 7 天),肺炎(20.6%)、呼吸机需求(7.6%)、急性呼吸窘迫综合征(ARDS,17.1%)、感染性休克(13.7%)和缺血性中风(5.8%)的发生率更高,而死亡率、再次手术和再入院率无显著差异。即使在检测呈阳性后 11-30 天手术延迟,以及在检测呈阳性后>30 天出现肺炎、ARDS 和感染性休克的情况下,呼吸机和中风的发生几率仍然更高。
与匹配的阴性患者相比,COVID-19 阳性患者的 30 天肺部、脓毒症和缺血性并发症增加。即使在检测呈阳性后超过 10 天,几种并发症的发生几率仍然持续存在。在对感染患者延迟手术的决策进行个体化风险分层时,应考虑肺部和动脉粥样硬化性合并症的风险。